Literature DB >> 14443779

Iron (II) inactivation of myeloperoxidase.

J SCHULTZ, S ROSENTHAL.   

Abstract

Entities:  

Keywords:  IRON/pharmacology; OXIDASES/antagonists

Mesh：

Substances：

Year:  1959        PMID： 14443779

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  10 in total

1.  Chloroma. Report of two cases with a brief review of the literature.

Authors:  A S Sethi
Journal:  Indian J Pediatr       Date:  1966-07       Impact factor: 1.967

2.  Iron and host defence.

Authors:  B S van Asbeck; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1983-02       Impact factor: 3.267

3.  Hairy cell sarcoma.

Authors:  J H Waxman
Journal:  Postgrad Med J       Date:  1983-01       Impact factor: 2.401

4.  Spontaneous Yersinia enterocolitica septicemia in a patient with iron overload.

Authors:  S S Larigakis; M A Noble; T G Sparling
Journal:  Can J Infect Dis       Date:  1990

5.  Effect of iron on leukocyte function: inactivation of H2O2 BY IRON.

Authors:  S S Kaplan; P G Quie; R E Basford
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

6.  Nude mice as models for human leukemia studies.

Authors:  G K Potter; R N Shen; J W Chiao
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

7.  Resistance to pesticin, storage of iron, and invasion of HeLa cells by Yersiniae.

Authors:  D J Sikkema; R R Brubaker
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Myeloperoxidase oxidation states involved in myeloperoxidase-oxidase oxidation of thiols.

Authors:  B E Svensson
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

9.  Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload.

Authors:  Y Waterlot; B Cantinieaux; C Hariga-Muller; E De Maertelaere-Laurent; J L Vanherweghem; P Fondu
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24

10.  Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed.

Authors:  Cyril Renassia; Sabine Louis; Sylvain Cuvellier; Nadia Boussetta; Jean-Christophe Deschemin; Didier Borderie; Karine Bailly; Joel Poupon; Pham My-Chan Dang; Jamel El-Benna; Sandra Manceau; François Lefrère; Sophie Vaulont; Carole Peyssonnaux
Journal:  Blood Adv       Date:  2020-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.